Search clinical trials for: thrombosis prophylaxis

Total 5644 results

Medical University of South Carolina
National Cancer Institute (NCI)

Not yet recruiting

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

Cancer | Surgery | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies (SmaVTE-BEST)

Venous Thromboembolism | Clinical Decision Support Systems | Digital Health
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management (SmaVTE-RCT)

Venous Thromboembolism | Health Education | Digital Health

China
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management (SmaVTE-COR)

Venous Thromboembolism | Health Education | Digital Health

China
West China Hospital
Beijing Friendship Hospital; Beijing YouAn Hospital; Beijing 302 Hospital; The...

Not yet recruiting

Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis

Portal Hypertension | Portal Vein Thrombosis | Portosystemic Shunt | Esophageal Varix Bleeding

China
Herlev Hospital

Recruiting

Study of Low Molecular Weight Heparins (DANHEP)

Venous Thromboembolism | Treatment | Prophylaxis | Anticoagulant

Denmark
MinaPharm Pharmaceuticals

Recruiting

Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis (Thromb-001)

Prophylaxis of Deep Vein Thrombosis

Egypt
Region Stockholm
Uppsala University

Recruiting

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation (SACK)

Stroke | Chronic Kidney Diseases | Death | Atrial Fibrillation | Intracerebral Hemorrhage | Kidney Transplant; Complications | Thromboses, Venous | Cardiovascular Complication | Major Bleed

Sweden, Norway, Finland, Iceland
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Regeneron Pharmaceuticals

Recruiting

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy (Honey-B)

Hemophilia B

United States, Germany, United Kingdom, Canada
Firstkind Ltd
National Institute for Health Research, United Kingdom; University of California and other collaborators

Recruiting

GEKO Venous Thromboembolism Prevention Study

Deep Vein Thrombosis | Venous Thromboembolism | Stroke, Acute | Pulmonary Embolism

United Kingdom
Manchester University NHS Foundation Trust
Manchester Academic Health Science Centre; Firstkind Ltd

Recruiting

Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical Care (ENSARIA)

Sepsis | Critical Illness | Venous Thromboembolism | Acute Illness

United Kingdom
Mount Sinai Hospital, Canada

Recruiting

Low Molecular Weight hEparin vs. Aspirin Post-partum (LEAP)

Venous Thromboembolism

Canada
André Luiz Malavasi Longo de Oliveira
Science Valley Research Institute

Recruiting

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin (VALERIA)

Cancer | Venous Thromboembolism | Rivaroxaban | Thromboprophylaxis

Brazil
Pirogov Russian National Research Medical University

Recruiting

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. (IDAHeT)

Venous Thromboembolism

Russian Federation
University of Limerick

Recruiting

A Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries. (TILLIRI)

Thromboses, Venous | Lower Limb Injury

Ireland
Karolinska University Hospital
Karolinska Institutet

Recruiting

A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study

Covid-19

Sweden
China-Japan Friendship Hospital

Recruiting

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Quality Improvement | Venous Thromboembolic Disease

China
China-Japan Friendship Hospital

Not yet recruiting

CHIPs-VTE Study in Hospitalized Patients With Lung Cancer

Pulmonary Embolism | Deep Venous Thrombosis | Venous Thromboembolic Disease
Washington Institute for Coagulation
Genentech, Inc.

Recruiting

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A (EmiMSK)

Hemophilia A

United States
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute

Recruiting

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) (PROTEST)

Traumatic Brain Injury

Canada
HK Surgical, Inc.
University of California, Riverside

Not yet recruiting

Tumescent Anesthesia Antibiotic Delivery (TAAD) (TAAD)

Sepsis | Thrombosis | Surgical Site Infection
PedNet Haemophilia Research Foundation
Lund University Hospital

Recruiting

The European Paediatric Network for Haemophilia Management ( PedNet Registry) (PedNet)

Factor IX Deficiency | Factor VIII Deficiency

Norway, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
Pfizer

Active, not recruiting

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Hemophilia A | Hemophilia B

United States, Canada, Spain, Australia, Korea, Republic of, Taiwan, Brazil, Italy, Japan, Turkey, Germany, United Kingdom, Saudi Arabia, France, Sweden, Belgium, Greece, Israel
Valleywise Health

Terminated

Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures

Surgical Blood Loss | Venous Thrombosis Deep (Limbs)

United States
Massachusetts General Hospital
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital

Enrolling by invitation

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Sarcoma | Soft Tissue Sarcoma | Venous Thromboembolism | Bone Metastases | Hematoma | Bone Sarcoma | Anticoagulant-induced Bleeding

United States
Stefan Holubar MD MS FACS, FASCRS

Withdrawn

SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery (SAVES-IBD)

Crohn Disease | Ulcerative Colitis | Venous Thromboembolism

United States
Indiana Hemophilia &Thrombosis Center, Inc.
Genentech, Inc.

Terminated

HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor

Haemophilic Pseudotumour

United States
Insel Gruppe AG, University Hospital Bern
Bayer; Janssen Pharmaceuticals

Completed

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery (BARIVA)

Bariatric Surgery

Switzerland
Bayer

Completed

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort (OSCAR-US)

Treatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

United States
Bayer

Completed

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis (TAURUS)

Hemophilia A, Congenital

Slovenia, Italy, Germany, France, United States, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan
Quovadis Associazione
Neopharmed Gentili S.p.A.

Active, not recruiting

Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

Superficial Venous Thrombosis of Leg, Secondary Prevention

Italy
Methodist Health System

Enrolling by invitation

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma

Thromboembolism, Venous

United States
Adient Medical
ICON plc; Avania

Active, not recruiting

US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism

Pulmonary Embolism

United States
Nordsjaellands Hospital
Hvidovre University Hospital; Bispebjerg Hospital; Herlev and Gentofte Hospital

Completed

VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

Colon Cancer | Deep Vein Thrombosis, Pulmonary Embolus
Sanofi

Active, not recruiting

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Venous Thromboembolism

United States
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Completed

Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis (ENACT)

Venous Thrombosis (Disorder)

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors (HAVEN 3)

Hemophilia A

Australia, Taiwan, Korea, Republic of, France, Germany, Italy, South Africa, Spain, United States, Japan, Ireland, Poland, United Kingdom, Costa Rica
Prairie Education and Research Cooperative
American College of Phlebology

Terminated

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

Deep Vein Thrombosis | Venous Thromboembolism | Coronary Artery Bypass Surgery
Brazilian Clinical Research Institute
Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaborators

Terminated

Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 (APOLLO)

Covid19 | Thrombosis

Brazil
McMaster University

Completed

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Surgery | Venous Thromboembolism | Adherence, Medication | Prophylaxis | Neoplasms Malignant

Canada
Eastern Virginia Medical School
GlaxoSmithKline

Terminated

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

Venous Thromboembolism
Science Valley Research Institute
Bayer

Completed

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial (MICHELLE)

Covid19 | Venous Thromboembolism

Brazil
Fadoi Foundation, Italy
University Of Perugia

Completed

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. (PRO-LAPSII)

Prevention of Venous Thromboembolism

Italy
Meir Medical Center

Completed

Anti-factor Xa Based Venous Thromboembolism Prophylaxis

Dose Adjustment of Enoxaparin in ICU Patients

Israel
Beijing Chao Yang Hospital

Completed

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients (VTEH)

Hemorrhage | Venous Thromboembolism

China
University of Maryland, Baltimore

Completed

A Different Approach to Preventing Thrombosis (ADAPT)

Venous Thromboembolism | Pulmonary Embolism

United States
Duke University
National Institutes of Health (NIH); National Institute on Aging (NIA); Hartford... and other collaborators

Completed

VTE Prophylaxis Guidelines in Hospitalized Elders

Venous Thromboembolism

United States

Search clinical trials for: thrombosis prophylaxis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations